Home Other Building Blocks 2776-93-4
2776-93-4,MFCD02259695
Catalog No.:AA00C43R

2776-93-4 | H-Asn(glcnac-beta-d)-oh

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
≥ 99% (TLC)
in stock  
$546.00   $383.00
- +
100mg
≥ 99% (TLC)
in stock  
$1,211.00   $848.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C43R
Chemical Name:
H-Asn(glcnac-beta-d)-oh
CAS Number:
2776-93-4
Molecular Formula:
C12H21N3O8
Molecular Weight:
335.3104
MDL Number:
MFCD02259695
SMILES:
OC[C@H]1O[C@@H](NC(=O)C[C@@H](C(=O)O)N)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C
Properties
Computed Properties
 
Complexity:
460  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
7  
Rotatable Bond Count:
6  
XLogP3:
-5.7  

Literature

Title: The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases.

Journal: Orphanet journal of rare diseases 20110101

Title: Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice.

Journal: Journal of inherited metabolic disease 20101001

Title: Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.

Journal: Acta radiologica (Stockholm, Sweden : 1987) 20080701

Title: The structural basis of the difference in sensitivity for PNGase F in the de-N-glycosylation of the native bovine pancreatic ribonucleases B and BS.

Journal: Biochemistry 20080318

Title: Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.

Journal: Journal of inherited metabolic disease 20061001

Title: Reduction in head size in patients with aspartylglucosaminuria.

Journal: Acta neurologica Scandinavica 20051101

Title: Massive accumulation of Man2GlcNAc2-Asn in nonneuronal tissues of glycosylasparaginase-deficient mice and its removal by enzyme replacement therapy.

Journal: Glycobiology 20050101

Title: Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors.

Journal: Transplantation 20040815

Title: Startle epilepsy complicating aspartylglucosaminuria.

Journal: Brain & development 20040301

Title: Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria.

Journal: The British journal of dermatology 20021001

Title: Glycosylasparaginase activity requires the alpha-carboxyl group, but not the alpha-amino group, on N(4)-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine.

Journal: Archives of biochemistry and biophysics 20010715

Title: Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria.

Journal: FEBS letters 20010615

Title: Synthesis of N4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-asparagine analogues. n-Butyramide, 3-chloropropionamide, 3-aminopropionamide, and isovaleramide analogues.

Journal: Carbohydrate research 20010423

Title: Co-existence of lysosomal storage diseases in a consanguineous family.

Journal: Child: care, health and development 20010301

Title: Glycosylasparaginase inhibition studies: competitive inhibitors, transition state mimics, noncompetitive inhibitors.

Journal: Journal of enzyme inhibition 20010101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 2776-93-4
Tags:2776-93-4 Molecular Formula|2776-93-4 MDL|2776-93-4 SMILES|2776-93-4 H-Asn(glcnac-beta-d)-oh